Can platelet-rich fibrin act as a natural carrier for antibiotics delivery? A proof-of-concept study for oral surgical procedures

被引:33
作者
Bennardo, Francesco [1 ]
Gallelli, Luca [2 ]
Palleria, Caterina [2 ]
Colosimo, Manuela [3 ]
Fortunato, Leonzio [1 ]
De Sarro, Giovambattista [2 ]
Giudice, Amerigo [1 ]
机构
[1] Magna Graecia Univ Catanzaro, Sch Dent, Dept Hlth Sci, Viale Europa, I-88100 Catanzaro, Italy
[2] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Pharmacol Unit, Catanzaro, Italy
[3] Pugliese Ciaccio Hosp, Microbiol & Virol Unit, Catanzaro, Italy
关键词
Antibiotics; Antimicrobial activity; Antimicrobial resistance; Drug delivery; Oral surgery; Platelet-rich fibrin; GROWTH-FACTORS; CELL; OSTEOBLASTS; VANCOMYCIN; RESISTANCE;
D O I
10.1186/s12903-023-02814-5
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
ObjectivesEvaluate the role of platelet-rich fibrin (PRF) as a natural carrier for antibiotics delivery through the analysis of drug release and antimicrobial activity.Materials and methodsPRF was prepared according to the L-PRF (leukocyte- and platelet-rich fibrin) protocol. One tube was used as control (without drug), while an increasing amount of gentamicin (0.25 mg, G1; 0.5 mg, G2; 0.75 mg, G3; 1 mg, G4), linezolid (0.5 mg, L1; 1 mg, L2; 1.5 mg, L3; 2 mg, L4), vancomycin (1.25 mg, V1; 2.5 mg, V2; 3.75 mg, V3; 5 mg, V4) was added to the other tubes. At different times the supernatant was collected and analyzed. Strains of E. coli, P. aeruginosa, S. mitis, H. influenzae, S. pneumoniae, S. aureus were used to assess the antimicrobial effect of PRF membranes prepared with the same antibiotics and compared to control PRF.ResultsVancomycin interfered with PRF formation. Gentamicin and linezolid did not change the physical properties of PRF and were released from membranes in the time intervals examined. The inhibition area analysis showed that control PRF had slight antibacterial activity against all tested microorganisms. Gentamicin-PRF had a massive antibacterial activity against all tested microorganisms. Results were similar for linezolid-PRF, except for its antibacterial activity against E. coli and P. aeruginosa that was comparable to control PRF.ConclusionsPRF loaded with antibiotics allowed the release of antimicrobial drugs in an effective concentration. Using PRF loaded with antibiotics after oral surgery may reduce the risk of post-operative infection, replace or enhance systemic antibiotic therapy while preserving the healing properties of PRF. Further studies are needed to prove that PRF loaded with antibiotics represents a topical antibiotic delivery tool for oral surgical procedures.
引用
收藏
页数:10
相关论文
共 60 条
[41]   Comparison of platelet-rich fibrin (PRF) produced using 3 commercially available centrifuges at both high (∼ 700 g) and low (∼ 200 g) relative centrifugation forces [J].
Miron, Richard J. ;
Xu, Hudi ;
Chai, Jihua ;
Wang, Jiaolong ;
Zheng, Shihang ;
Feng, Mengge ;
Zhang, Xiaoxin ;
Wei, Yan ;
Chen, Yan ;
Mourao, Carlos Fernando de Almeida Barros ;
Sculean, Anton ;
Zhang, Yufeng .
CLINICAL ORAL INVESTIGATIONS, 2020, 24 (03) :1171-1182
[42]   The effect of age, gender, and time between blood draw and start of centrifugation on the size outcomes of platelet-rich fibrin (PRF) membranes [J].
Miron, Richard J. ;
Dham, Anika ;
Dham, Uttma ;
Zhang, Yufeng ;
Pikos, Michael A. ;
Sculean, Anton .
CLINICAL ORAL INVESTIGATIONS, 2019, 23 (05) :2179-2185
[43]   Autologous liquid platelet rich fibrin: A novel drug delivery system [J].
Miron, Richard J. ;
Zhang, Yufeng .
ACTA BIOMATERIALIA, 2018, 75 :35-51
[44]  
Miron RJ, 2017, TISSUE ENG PART B-RE, V23, P83, DOI [10.1089/ten.teb.2016.0233, 10.1089/ten.TEB.2016.0233]
[45]  
Mohsen S, 2020, CAN FAM PHYSICIAN, V66, P651
[46]   Local antibiotic delivery systems for the treatment of osteomyelitis - A review [J].
Nandi, Samit Kumar ;
Mukherjee, Prasenjit ;
Roy, Subhasis ;
Kundu, Biswanath ;
De, Dipak Kumar ;
Basu, Debabrata .
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2009, 29 (08) :2478-2485
[47]   Incorporating antibiotics into platelet-rich fibrin: A novel antibiotics slow-release biological device [J].
Polak, David ;
Clemer-Shamai, Navit ;
Shapira, Lior .
JOURNAL OF CLINICAL PERIODONTOLOGY, 2019, 46 (02) :241-247
[48]  
Rechichi Miguel, 2020, Am J Ophthalmol Case Rep, V20, P100838, DOI 10.1016/j.ajoc.2020.100838
[49]   The use of growth factors, CD34+ cells and fibrin for the management of chronic venous ulcers [J].
Romano, Francesco ;
Paolino, Francesco M. ;
Rizzo, Barbara A. ;
Russo, Antonio ;
Southworth, Stephen ;
Serra, Raffaele ;
Gallelli, Luca .
INTERNATIONAL WOUND JOURNAL, 2016, 13 (05) :1011-1013
[50]   Antimicrobial Resistance and Susceptibility Testing of Anaerobic Bacteria [J].
Schuetz, Audrey N. .
CLINICAL INFECTIOUS DISEASES, 2014, 59 (05) :698-705